Seventy-nine percent of medical groups report that Medicare does not offer a clinically relevant advanced alternative payment model for their specialty despite most expressing interest in one for quality measure alignment, according to a MGMA poll published July 19.
The association argues that the lack of clinically relevant APMs available is a significant barrier for medical groups seeking to transition away from fee for service.
“With physician practices facing annual Medicare payment cuts, they continue to look for APMs that support their efforts to deliver high-quality cost-effective care. Unfortunately, the majority of medical groups do not have a clinically relevant option and find themselves stuck in fee-for-service,” MGMA Senior Vice President of Government Affairs Anders Gilberg said.
“Congress empowered a physician advisory group to vet and advance physician-led alternative APMs, but to date CMS has failed to implement any of its recommendations. As it examines new approaches to payment and quality, CMS must trust physicians to lead these efforts and recognize the best ideas for value-based care won’t come from a top-down government approach,” Mr. Gilberg said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
